Share on StockTwits
 

Equities research analysts at BMO Capital Markets upped their price target on shares of Wright Medical (NASDAQ: WMGI) from $25.00 to $26.00 in a research note issued to investors on Wednesday. The firm currently has an “outperform” rating on the stock.

Several other analysts have also recently commented on the stock. Analysts at Jefferies Group reiterated a “hold” rating on shares of Wright Medical in a research note to investors on Wednesday, March 6th. They now have a $24.00 price target on the stock, up previously from $21.00. Separately, analysts at JPMorgan Chase initiated coverage on shares of Wright Medical in a research note to investors on Tuesday, March 5th. They set an “overweight” rating on the stock. Finally, analysts at Mizuho raised their price target on shares of Wright Medical from $25.00 to $30.00 in a research note to investors on Tuesday, March 5th. They now have a “buy” rating on the stock.

Four equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $25.00.

Wright Medical (NASDAQ: WMGI) traded down 1.40% on Wednesday, hitting $23.27. Wright Medical has a 1-year low of $17.88 and a 1-year high of $24.58. The stock’s 50-day moving average is currently $22.7. The company has a market cap of $904.9 million and a price-to-earnings ratio of 173.53.

Wright Medical (NASDAQ: WMGI) last issued its quarterly earnings data on Thursday, February 21st. The company reported $0.01 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.02) by $0.03. The company had revenue of $123.50 million for the quarter, compared to the consensus estimate of $120.93 million. During the same quarter last year, the company posted $0.17 earnings per share. Wright Medical’s revenue was down 2.7% compared to the same quarter last year. Wright Medical has set its FY13 guidance at $0.00-0.06 EPS. Analysts expect that Wright Medical will post $-0.29 EPS for the current fiscal year.

Wright Medical Group, Inc. (NASDAQ: WMGI) through its subsidiary Wright Medical Technology Inc, and other operating subsidiaries is an orthopaedic medical device company engaged in the design, manufacture and marketing of devices and biologic products for extremity, hip, and knee repair and reconstruction.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.